Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

274 questions in 25 reviews · Movement Disorders

current versions
No studies 13 · 4.7%Ungraded 7 · 2.6%Very low 66 · 24.1%Low 66 · 24.1%Moderate 87 · 31.8%High 35 · 12.8%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
BoNT‐A/OT vs Placebo/no treatment
Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 33 participantsHigh
BoNT‐A/OT vs Placebo/no treatment
Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 35 participantsHigh
BoNT‐A/OT vs Placebo/no treatment
Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 35 participantsHigh
BoNT‐A only vs OT only
Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 35 participantsHigh
BoNT‐A vs Placebo/no treatment
Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 13 participantsModerate
BoNT‐A only vs OT only
Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 35 participantsModerate
BoNT‐A only vs OT only
Quality of movement (18 mths ‐ 8yrs) QUEST. Scale from: 0 to 100. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 13 participantsModerate
BoNT‐A only vs OT only
Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 21 participantsModerate
BoNT‐A only vs OT only
Goal attainment Goal attainment scaling3. Scale from: 20 to 80. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 36 participantsModerate
BoNT‐A only vs OT only
Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 36 participantsModerate
BoNT‐A only vs OT only
Occupational performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 36 participantsModerate
High dose BoNT‐A vs Low dose BoNT‐A
Elbow flexor spasticity · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted0 studies · 1 participantsUngraded
High dose BoNT‐A vs Low dose BoNT‐A
Wrist flexor spasticity · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted0 studies · 1 participantsUngraded
High dose BoNT‐A vs Low dose BoNT‐A
Quality of movement (18 mths ‐ 8yrs) Quality of Upper Extremity Skills Test. Scale from: 0 to 100. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 39 participantsModerate
High dose BoNT‐A vs Low dose BoNT‐A
Goal attainment · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted0 studies · 1 participantsUngraded
BoNT‐A vs Placebo/no treatment
Quality of movement (5 yrs ‐ 15yrs) The Melbourne Assessment. Scale from: 0 to 100. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 21 participantsModerate
High dose BoNT‐A vs Low dose BoNT‐A
Quality of movement (5 yrs to 15 yrs) · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted0 studies · 1 participantsUngraded
High dose BoNT‐A vs Low dose BoNT‐A
Occupational performance ‐ performance · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted0 studies · 1 participantsUngraded
High dose BoNT‐A vs Low dose BoNT‐A
Occupational performance ‐ satisfaction · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted0 studies · 1 participantsUngraded
BoNT‐A vs Placebo/no treatment
Goal attainment Goal Attainment Scaling3. Scale from: 20 to 80. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 32 participantsModerate
BoNT‐A vs Placebo/no treatment
Occupational performance ‐ performance Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 34 participantsHigh
BoNT‐A vs Placebo/no treatment
Occuptional performance ‐ satisfaction Canadian Occupational Performance Measure. Scale from: 0 to 10. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 34 participantsHigh
BoNT‐A/OT vs OT only
Elbow flexor spasticity modified Tardieu scale. Scale from: 0 to 180. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 36 participantsHigh
BoNT‐A/OT vs OT only
Wrist flexor spasticity modified Tardieu scale. Scale from: 0 to 90. · children with cerebral palsy
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic… (2010) · Cochrane
no estimate extracted1 study · 36 participantsHigh